Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupa R Patel

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Annals of Epidemiology|March 19, 2026
Quantifying the number of people who would benefit from HIV pre-exposure prophylaxis (PrEP) in the United States: a comparison of behavioral, acquisition-risk based, and economic metricsRonn Minttu M Rönn, Athena P Kourtis, Yizhi Liang, et al.
AIDS Care|October 10, 2022
Factors associated with suboptimal retention in HIV pre-exposure prophylaxis care among men who have sex with menBrooke G Rogers, Collette Sosnowy, Philip A Chan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 9, 2025
Impact of Social Determinants of Health on Pre-Exposure Prophylaxis Care for HIV PreventionPhilip A Chan, William C Goedel, Yu Li, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 12, 2022
Pre-exposure Prophylaxis Discontinuation During the COVID-19 Pandemic Among Men Who Have Sex With Men in a Multisite Clinical Cohort in the United StatesWilliam C Goedel, Brooke G Rogers, Yu Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2026
Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure ProphylaxisAniruddha Hazra, Philip A Chan, Meredith Clement, et al.
Open Forum Infectious Diseases|September 4, 2024
First Case of HIV Seroconversion With Integrase Resistance Mutations on Long-Acting Cabotegravir for Prevention in Routine CareCatherine A Koss, Monica Gandhi, Elias K Halvas, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Annals of Epidemiology|March 19, 2026
Quantifying the number of people who would benefit from HIV pre-exposure prophylaxis (PrEP) in the United States: a comparison of behavioral, acquisition-risk based, and economic metricsRonn Minttu M Rönn, Athena P Kourtis, Yizhi Liang, et al.
AIDS Care|October 10, 2022
Factors associated with suboptimal retention in HIV pre-exposure prophylaxis care among men who have sex with menBrooke G Rogers, Collette Sosnowy, Philip A Chan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 9, 2025
Impact of Social Determinants of Health on Pre-Exposure Prophylaxis Care for HIV PreventionPhilip A Chan, William C Goedel, Yu Li, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 12, 2022
Pre-exposure Prophylaxis Discontinuation During the COVID-19 Pandemic Among Men Who Have Sex With Men in a Multisite Clinical Cohort in the United StatesWilliam C Goedel, Brooke G Rogers, Yu Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2026
Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure ProphylaxisAniruddha Hazra, Philip A Chan, Meredith Clement, et al.
Open Forum Infectious Diseases|September 4, 2024
First Case of HIV Seroconversion With Integrase Resistance Mutations on Long-Acting Cabotegravir for Prevention in Routine CareCatherine A Koss, Monica Gandhi, Elias K Halvas, et al.
Pageof 5